Startups
OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI acquired drug development software startup Orchestra Bio to integrate AI agents into pharmaceutical development workflows within its Rosalind life sciences division.
Also covered by 1 other outlet